In 2024, Esperite's return on equity (ROE) was 0, a 0% increase from the 0 ROE in the previous year.

Esperite Aktienanalyse

What does Esperite do?

Esperite NV is a company based in the Netherlands that specializes in the development, production, and marketing of stem cell and cell therapies. It focuses on creating groundbreaking therapies for the treatment of serious diseases and aims to market them worldwide. Its business model includes three main segments: Life Science, Consumer Healthcare, and Branding. The Life Science segment focuses on developing stem cell and cell therapies for the treatment of diseases such as autism, cancer, and degenerative disorders. The Consumer Healthcare segment offers products related to pregnancy and fertility assistance. The Branding segment involves the development and marketing of high-quality cosmetic products. Esperite's flagship product is CryoSave, a solution for the long-term preservation of stem cells from umbilical cord blood. Esperite ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Esperite's Return on Equity (ROE)

Esperite's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Esperite's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Esperite's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Esperite’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Esperite stock

What is the ROE (Return on Equity) of Esperite this year?

The ROE of Esperite this year is 0 undefined.

How has the Return on Equity (ROE) of Esperite developed compared to the previous year?

The ROE of Esperite has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Esperite?

A high ROE indicates that Esperite generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Esperite?

A low ROE can indicate that Esperite is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Esperite affect the company?

A change in ROE (Return on Equity) of Esperite can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Esperite?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Esperite?

Some factors that can influence Esperite's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Esperite pay?

Over the past 12 months, Esperite paid a dividend of 0.08 EUR . This corresponds to a dividend yield of about 869.57 %. For the coming 12 months, Esperite is expected to pay a dividend of 0 EUR.

What is the dividend yield of Esperite?

The current dividend yield of Esperite is 869.57 %.

When does Esperite pay dividends?

Esperite pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Esperite?

Esperite paid dividends every year for the past 0 years.

What is the dividend of Esperite?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Esperite located?

Esperite is assigned to the 'Health' sector.

Wann musste ich die Aktien von Esperite kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Esperite from 6/14/2012 amounting to 0.08 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2012.

When did Esperite pay the last dividend?

The last dividend was paid out on 6/14/2012.

What was the dividend of Esperite in the year 2023?

In the year 2023, Esperite distributed 0 EUR as dividends.

In which currency does Esperite pay out the dividend?

The dividends of Esperite are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Esperite

Our stock analysis for Esperite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Esperite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.